期刊文献+

药物临床试验中伦理审查存在的问题与对策 被引量:10

Problems and Strategies of Ethic Censorship in Clinical Trials
下载PDF
导出
摘要 对我国目前药物临床试验伦理审查存在的问题进行了分析,并提出通过建立完善的伦理审查程序和审查标准,加强伦理委员会成员的培训,加大国际间的交流及监管力度等措施,提高伦理审查的质量和水平,以保障受试者的合法权益和临床研究的科学性和可靠性。 To make the pharmaceutical clinical trials meet the ethic standard in our country, we make an analysis of the problems of current ethics censorship in this field. Moreover, we claim that for the purpose of scientific and reliable clinical research, the legal rights of subjects and the quality increase of ethics censorship, it is necessary to establish complete ethics censorship procedure and standard, intensify the training of the ethics committee's members, set up supervisory system and promote international community.
作者 王荣梅
出处 《中国医学伦理学》 2007年第1期35-36,共2页 Chinese Medical Ethics
关键词 药物临床试验 伦理审查 受试者 pharmaceutical clinical trial ethic censorship subject
  • 相关文献

参考文献2

二级参考文献7

  • 1[1]Cynthia McGuire Dunn, MD, & Gary L, Chadwick, Pharm D,MPH, CIP. Protecting study volunteers in research[J]. CenterWatch, a division of Thomson Healthcare, Inc. 2002
  • 2[2]Robin Levin, Penslar, Joan P, Porter. Institutional Review Board Guidebook[S]. 1993. http://www. hhs. gov/ohrp/irb/irb-chapter3. htm
  • 3[3]Identification and recruitment of research subjects. Institutional Review Board Manual: 15 - 1. http://www. mayoclinic. org/confidentiality/rst- irb15 - 1. html
  • 4[4]CIOMS. International Ethical Guidelines for Biomedical Research Involving Human Subjects[ S]. 2002
  • 5卜擎燕,熊宁宁,吴静.人体生物医学研究国际道德指南[J].中国临床药理学与治疗学,2003,8(1):107-110. 被引量:50
  • 6卜擎燕,熊宁宁,吴静.临床试验中特殊受试人群选择的国际伦理要求[J].中国临床药理学与治疗学,2003,8(3):356-360. 被引量:17
  • 7汪秀琴,熊宁宁,刘沈林,李七一,蒋萌,刘芳,邹建东,卜擎燕,高维敏.临床试验的伦理审查:知情同意[J].中国临床药理学与治疗学,2004,9(1):117-120. 被引量:40

共引文献95

同被引文献77

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部